C
Cardio Diagnostics Holdings D
D
CDIO
1.72000
USD
-0.13
(-7.03%)
Market Closed
Volume
361
EPS
0
Div Yield
-
P/E
-0
Market Cap
5,090,287
Title: Cardio Diagnostics Holdings Inc.
Sector: Healthcare
Industry: Biotechnology
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.